Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthesia is a prominent European specialty chemicals manufacturer based in the Czech Republic, specializing in the production of nitrocellulose, organic pigments, and pharmaceutical intermediates. As one of the world's leading suppliers of nitrocellulose, the company provides essential materials for industrial coatings, printing inks, and high-precision diagnostic membranes used in life science applications. Their healthcare portfolio includes oxidized cellulose products, marketed under the OKCEL brand, which are used as absorbable hemostats in surgical procedures. Synthesia serves as a critical partner in the global chemical and pharmaceutical supply chains, offering custom synthesis and large-scale manufacturing capabilities for complex organic molecules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthesia Nitrocellulose.